am 580 has been researched along with ac 261066 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brann, MR; Currier, E; Eeg, A; Gauthier, NK; Hacksell, U; Lund, BW; Olsson, R; Piu, F; Sherbukhin, V | 1 |
| Begtrup, M; Gauthier, NK; Hacksell, U; Knapp, AE; Lund, BW; Olsson, R; Piu, F | 1 |
2 other study(ies) available for am 580 and ac 261066
| Article | Year |
|---|---|
Discovery of a potent, orally available, and isoform-selective retinoic acid beta2 receptor agonist.
Topics: Administration, Oral; Animals; Benzoates; Binding Sites; Biological Availability; Biphenyl Compounds; Cells, Cultured; Humans; Models, Molecular; Protein Isoforms; Protein Structure, Tertiary; Rats; Receptors, Retinoic Acid; Solubility; Structure-Activity Relationship; Thiazoles; Transcription, Genetic | 2005 |
Design, synthesis, and structure-activity analysis of isoform-selective retinoic acid receptor beta ligands.
Topics: Cell Line, Tumor; Drug Design; Humans; Ligands; Receptors, Retinoic Acid; Structure-Activity Relationship | 2009 |